Table 1.
Baseline characteristics of the study participants according to sex.
| Overall | Male | Female | p-value | |
|---|---|---|---|---|
| Number (n) | 410 | 304 | 106 | – |
| Age (years) | 36.0 ± 11.0 | 37.0 ± 11.0 | 34.0 ± 11.0 | 0.105 |
| Weight (kg) | 66.1 ± 11.2 | 67.6 ± 10.6 | 58.4 ± 11.5 | 0.000 |
| Height (cm) | 163.8 ± 12.2 | 166.1 ± 6.4 | 151.3 ± 23.7 | 0.000 |
| BMI (kg/m2) | 24.4 ± 3.5 | 24.5 ± 3.4 | 24.3 ± 4.1 | 0.860 |
| WC (cm) | 84.2 ± 12.3 | 84.9 ± 12.5 | 80.8 ± 10.6 | 0.078 |
| SBP (mmHg) | 124.0 ± 12.0 | 125.0 ± 12.0 | 120.0 ± 13.0 | 0.041 |
| DBP (mmHg) | 83.0 ± 10.0 | 83.0 ± 10.0 | 82.0 ± 10.0 | 0.467 |
| PP (beats/min) | 76.0 ± 12.0 | 75.0 ± 12.0 | 81.0 ± 12.0 | 0.006 |
| FBG (mmol/L) | 5.2 ± 0.7 | 5.2 ± 0.7 | 5.3 ± 0.9 | 0.355 |
| TG (mg/dL) | 172.8 ± 97.3 | 181.3 ± 100.8 | 128.4 ± 60.1 | 0.000 |
| TC (mg/dL) | 195.2 ± 59.2 | 195.2 ± 62.5 | 195.0 ± 38.6 | 0.976 |
| HDL-C (mg/dL) | 31.7 ± 9.8 | 31.0 ± 10.0 | 35.1 ± 7.6 | 0.004 |
| LDL-C (mg/dL) | 130.0 ± 51.9 | 129.9 ± 54.5 | 130.5 ± 36.4 | 0.922 |
| SUA (µmol/L) | 374.3 ± 102.1 | 389.3 ± 96.9 | 290.4 ± 89.8 | 0.000 |
| ALT (U/L) | 33.1 ± 15.9 | 34.5 ± 16.0 | 25.0 ± 13.0 | 0.000 |
| AST (U/L) | 25.1 ± 11.0 | 25.9 ± 11.1 | 21.2 ± 10.1 | 0.036 |
| GGT (U/L) | 25.7 ± 18.9 | 26.7 ± 19.5 | 19.5 ± 13.2 | 0.004 |
| ALP (U/L) | 97.4 ± 35.5 | 99.4 ± 35.3 | 86.7 ± 35.0 | 0.101 |
| Hyperuricemia (%) | 30.1 | 32.2 | 18.6 | – |
Values are presented as mean ± SD. p-values are given for differences between the gender groups, obtained from an independent sample t test. BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, PP pulse pressure, FBG fasting blood glucose, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, SUA serum uric acid, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma glutamyltransferase, ALP alkaline phosphatase.